Results 21 to 30 of about 576,044 (343)
The new medical model: a renewed challenge for biomedicine [PDF]
, 2017 Over the past 25 years, several new “medicines” have come screeching onto health care’s various platforms, including narrative medicine, personalized medicine, precision medicine and person-centred medicine.
Fuller, Jonathan
core +1 more source
Personalized medicine : the impact on chemistry [PDF]
, 2010 An effective strategy for personalized medicine requires a major conceptual change in the development and application of therapeutics. In this article, we argue that further advances in this field should be made with reference to another conceptual shift,
Marsh, Andrew +3 more
core +1 more source
Communications Biology, 2022 A genome-wide association study in a Chinese population identifies SNPs associated with serum copper levels. Mendelian randomization analysis reveals causal effects on multiple human phenotypes in East Asian and European populations.
Wenjun Yang +11 more
doaj +1 more source
Clinical applications of personalized medicine: a new paradigm and challenge [PDF]
, 2017 The personalized medicine is an emergent and rapidly developing method of clinical practice that uses new technologies to provide decisions in regard to the prediction, prevention, diagnosis and treatment of disease.
Borro, Marina +7 more
core +1 more source
Personalized medicine—a modern approach for the diagnosis and management of hypertension [PDF]
, 2017 The main goal of treating hypertension is to reduce blood pressure to physiological levels and thereby prevent risk of cardiovascular disease and hypertension-associated target organ damage.
Borghi, Claudio +5 more
core +1 more source
Personalized Medicine: Pharmacokinetics
Journal of Personalized Medicine, 2022 The “one-size fits all” model that has been used for decades is now replaced by the concept of the “right dose of the right drug for the right patient” [...]
openaire +3 more sources
DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
Experimental and Molecular Medicine, 2023 Increasing evidence indicates that DNA damage-induced apoptosis suppressor (DDIAS) is an oncogenic protein that is highly expressed in a variety of cancers, including colorectal cancer, lung cancer, breast cancer, and hepatocellular carcinoma (HCC).
Joo-Young Im +3 more
doaj +1 more source
Is personalized medicine achievable in obstetrics? [PDF]
, 2014 Personalized medicine seeks to identify the right dose of the right drug for the right patient at the right time. Typically, individualization of therapy is based on the pharmacogenomic makeup of the individual and environmental factors that alter drug ...
Flockhart, David A. +2 more
core +1 more source
Pharmacogenetics and personalized medicine
Saúde & Tecnologia, 2016 Pharmacogenetics aims to identify genetic differences between individuals that may influence the response to drug therapy, improving their effectiveness and safety. Associated with the pharmacogenetics emerges ‘personalized medicine’.
Miguel Brito
doaj +1 more source
Ethical qualms about genetic prognosis [PDF]
, 2016 The debate about direct-to-consumer genetic testing has centred on whether consumers are the best judges of their own clinical care. Inthis article, I also examine whether the science of personalized medicine is really as advanced as its proponents
Dickenson, Donna
core +1 more source